Confluent Health proudly announces the rebranding of IncreMedical Therapy Solutions to Confluent Health System Solutions. This evolution reflects the commitment to partnering with health systems ...
Confluent’s financial performance doesn’t match its premium pricing. Learn why CFLT stock is risky given its minimal ...
Scotiabank analyst Nick Altmann maintained a Hold rating on Confluent (CFLT – Research Report) today and set a price target of $27.00. The ...
JMP Securities maintained a bullish stance on Confluent Inc (NASDAQ:CFLT), reiterating a Market Outperform rating and a ...
JMP Securities analyst Patrick Walravens maintained a Buy rating on Confluent (CFLT – Research Report) today and set a price target of $40.00.
In the last three months, 11 analysts have published ratings on Confluent (NASDAQ:CFLT), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed view ...
A large Louisville-based health care firm has made a pair of key C-suite appointments. Confluent Health announced this week ...
Confluent (NASDAQ:CFLT – Free Report) had its price objective hoisted by Guggenheim from $32.00 to $35.00 in a research note released on Friday morning,Benzinga reports. Guggenheim currently has a buy ...
Confluent is a terrific "growth at a reasonable price" software stock that has only seen its share price rise ~20% over the past year, despite strong growth. Confluent, founded by creators of open ...
Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...
Bestow, a leading insurance technology platform, today announces the addition of three new hires that will help drive its next growth phase. These leaders reinforce Bestow's ability to unlock digital ...
DeWanda Wise will star in “Killer Bee,” an adaptation of the upcoming graphic novel from David Crownson that Tommy Oliver ’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results